Focal irreversible electroporation for prostate cancer: functional outcomes and short-term oncological control (Q40440753)

20 September 2017

Focal irreversible electroporation for prostate cancer: functional outcomes and short-term oncological control (English)

1 reference

20 September 2017

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26458959%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Phillip D Stricker

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26458959%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

M Tran

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26458959%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

M Böhm

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26458959%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

A Siriwardana

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26458959%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

P J Van Leeuwen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26458959%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

A M Haynes

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26458959%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

W Delprado

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26458959%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

R Shnier

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26458959%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

publication date

13 October 2015

1 reference

Prostate Cancer and Prostatic Diseases

20 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26458959%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26458959%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26458959%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

46-52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26458959%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/pcan.2015.47

4 June 2020

exact match

0 references

cites work

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.47

Overdiagnosis and overtreatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.47

Screening and prostate-cancer mortality in a randomized European study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.47

The independent impact of extended pattern biopsy on prostate cancer stage migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.47

Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.47

Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.47

Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.47

The role of focal therapy in the management of localised prostate cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.47

Irreversible electroporation: implications for prostate ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.47

Electron microscopic demonstration and evaluation of irreversible electroporation-induced nanopores on hepatocyte membranes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.47

Initial assessment of safety and clinical feasibility of irreversible electroporation in the focal treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.47

The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.47

A prospective development study investigating focal irreversible electroporation in men with localised prostate cancer: Nanoknife Electroporation Ablation Trial (NEAT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.47

ESUR prostate MR guidelines 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.47

Optimal parameters for the destruction of prostate cancer using irreversible electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.47

Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.47

Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.47

Focal therapy: patients, interventions, and outcomes--a report from a consensus meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.47

Image Guided Focal Therapy for Magnetic Resonance Imaging Visible Prostate Cancer: Defining a 3-Dimensional Treatment Margin Based on Magnetic Resonance Imaging Histology Co-Registration Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.47

In vivo results of a new focal tissue ablation technique: irreversible electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.47

The effect of irreversible electroporation on blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.47

No surgical innovation without evaluation: the IDEAL recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.47

IDEAL framework for surgical innovation 1: the idea and development stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.47

Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.47

In vivo characterization and numerical simulation of prostate properties for non-thermal irreversible electroporation ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.47

Focal Ablation Targeted to the Index Lesion in Multifocal Localised Prostate Cancer: a Prospective Development Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.47

Bilateral focal ablation of prostate tissue using low-energy direct current (LEDC): a preclinical canine study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2015.47

A randomized controlled trial on focal therapy for localized prostate carcinoma: hemiablation versus complete ablation with irreversible electroporation

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26458959